CINECA IRIS Institutional Research Information System

YOUNES, Ramy
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.864
AS - Asia 2.799
EU - Europa 2.275
SA - Sud America 218
OC - Oceania 72
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 5
Totale 9.285
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.527
CN - Cina 1.777
IT - Italia 530
CA - Canada 275
SE - Svezia 229
JP - Giappone 226
GB - Regno Unito 204
DE - Germania 202
IE - Irlanda 193
IN - India 191
FR - Francia 172
ES - Italia 146
BR - Brasile 124
UA - Ucraina 108
KR - Corea 98
TW - Taiwan 81
HK - Hong Kong 74
VN - Vietnam 73
AU - Australia 67
GR - Grecia 64
MX - Messico 58
AT - Austria 56
PL - Polonia 54
TR - Turchia 54
SG - Singapore 52
BE - Belgio 38
FI - Finlandia 38
DK - Danimarca 36
NL - Olanda 36
ID - Indonesia 35
EG - Egitto 32
RU - Federazione Russa 31
CH - Svizzera 28
IR - Iran 28
PT - Portogallo 26
CO - Colombia 24
IL - Israele 24
SA - Arabia Saudita 23
AR - Argentina 22
CL - Cile 21
PE - Perù 17
RO - Romania 15
TH - Thailandia 14
BG - Bulgaria 13
PH - Filippine 13
NO - Norvegia 10
HU - Ungheria 9
MY - Malesia 9
CZ - Repubblica Ceca 8
HR - Croazia 8
EC - Ecuador 7
AE - Emirati Arabi Uniti 6
CV - Capo Verde 6
EU - Europa 5
KE - Kenya 5
NZ - Nuova Zelanda 5
LT - Lituania 4
BY - Bielorussia 3
LB - Libano 3
MA - Marocco 3
MK - Macedonia 3
MO - Macao, regione amministrativa speciale della Cina 3
RS - Serbia 3
BD - Bangladesh 2
IQ - Iraq 2
KZ - Kazakistan 2
LV - Lettonia 2
MD - Moldavia 2
OM - Oman 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
VE - Venezuela 2
ZA - Sudafrica 2
BO - Bolivia 1
CM - Camerun 1
CR - Costa Rica 1
CU - Cuba 1
CY - Cipro 1
GH - Ghana 1
HN - Honduras 1
JO - Giordania 1
LU - Lussemburgo 1
MN - Mongolia 1
NG - Nigeria 1
NI - Nicaragua 1
PS - Palestinian Territory 1
QA - Qatar 1
SC - Seychelles 1
SI - Slovenia 1
Totale 9.285
Salva come PNG Salva come JPEG
Città #
Chandler 386
Beijing 301
Redwood City 253
Ann Arbor 247
Fairfield 245
Shanghai 205
Ottawa 196
Dublin 188
Ashburn 145
Guangzhou 126
Houston 122
Woodbridge 110
Torino 105
Seattle 100
Wilmington 96
Dearborn 92
Hangzhou 92
Nanjing 75
Wuhan 74
Jacksonville 69
Medford 64
Cambridge 57
Princeton 53
Tokyo 52
Dong Ket 51
Chengdu 50
Pisa 48
London 43
Nyköping 43
Taipei 43
New York 42
Vienna 42
Seoul 35
Villeurbanne 33
Fremont 32
Turin 32
Central District 30
Changsha 30
Zhengzhou 30
Hefei 29
Changchun 28
Sydney 28
Chongqing 26
Jinan 26
Barcelona 25
Singapore 25
Tianjin 25
Shenyang 24
Boston 22
Duncan 22
Kolkata 22
São Paulo 22
San Diego 21
Rome 20
San Mateo 20
Santiago 19
Warsaw 19
Washington 19
Toronto 18
Brussels 17
Chennai 16
Madrid 16
Norwalk 16
Paris 16
Redmond 16
Rio de Janeiro 16
Rochester 16
Athens 15
Lima 14
Helsinki 13
Istanbul 13
Jakarta 13
Jeddah 13
Los Angeles 13
Naples 13
Boardman 12
Central 12
Copenhagen 12
Falls Church 12
Amsterdam 11
Buenos Aires 11
Cairo 11
Delhi 11
Düsseldorf 11
Manchester 11
Nanchang 11
Salvador 11
Fuzhou 10
Kunming 10
Mexico 10
New Haven 10
Xian 10
Zhangjiagang 10
Bogotá 9
Chicago 9
Hyderabad 9
Khandwa 9
Kofu 9
Milan 9
Pune 9
Totale 4.992
Salva come PNG Salva come JPEG
Nome #
Progression and Natural History of Nonalcoholic Fatty Liver Disease in Adults 1.197
Lean NAFLD: A Distinct Entity Shaped by Differential Metabolic Adaptation 1.185
Crosstalk between adipose tissue insulin resistance and liver macrophages in non-alcoholic fatty liver disease 868
NASH in lean individuals 803
Should we undertake surveillance for HCC in patients with NAFLD? 510
A spotlight on pathogenesis, interactions and novel therapeutic options in NAFLD 504
Usefulness of the index of NASH – ION for the diagnosis of steatohepatitis in patients with Non-Alcoholic Fatty Liver: an external validation study 481
Circulating Zonulin is Related to Hepatic Necroinflammation in Patients with Non Alcoholic Fatty Liver Disease 234
Peripheral insulin resistance predicts liver damage in nondiabetic subjects with nonalcoholic fatty liver disease 178
The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non-alcoholic fatty liver disease 174
LIVER DAMAGE CAN BE ASSOCIATED WITH DEREGULATION OF THE DE NOVO LIPOGENESIS PATHWAY IN SUBJECTS WITH NON ALCOHOLIC FATTY LIVER DISEASE 166
Plasma Selenoprotein P levels are related to adipose tissue insulin resistance, composition of free fatty acids and liver fibrosis in non-diabetic patients with Non Alcoholic Fatty Liver Disease 157
Clinical outcomes in chronic hepatitis C long-term responders to pre-direct antiviral agents: a single center retrospective study 154
Analytical and clinical evaluation of a novel assay for anti-HBc IgG measurement in serum of subjects with overt and occult HBV infection 144
Risk factors for metabolic syndrome after liver transplantation: what has changed over time 124
Insulin secretion and decreased glucose clearance are associated with enhanced fibrogenesis and a high risk of disease progression in non-diabetic patients with Non Alcoholic Fatty Liver Disease 121
In non obese NAFLD increased plasma saturated fatty acids and insulin resistance are metabolic signatures of severity of liver disease 117
The Impact of Metabolic Syndrome on the Outcome of NASH: Cirrhosis, Hepatocellular Carcinoma, and Mortality 106
Altered metabolic profile and adipocyte insulin resistance mark severe liver fibrosis in patients with chronic liver disease 103
Bile acids composition modulate insulin resistance in non-diabetic patients with NAFLD 102
On-Treatment Decrease of Serum Interleukin-6 as a Predictor of Clinical Response to Biologic Therapy in Patients with Inflammatory Bowel Diseases 100
DEREGULATION OF DE NOVO LIPOGENESIS CAN BE ASSOCIATED WITH LIVER DAMAGE IN PATIENTS WITH NON ALCOHOLIC FATTY LIVER DISEASE 98
Microangiopathic hemolytic anemia caused by a signet-ring cell carcinoma of the intrahepatic bile duct 98
Comment on helicobacter pylori eradication using metronidazole 94
Hepatocellular carcinoma and metabolic risk factors in a main reference center in Italy 93
Prevalence of patients with non-alcoholic fatty liver disease: from primary care to tertiary centers. The Turin experience 93
Risk factors for arterial hypertension after liver transplantation 89
Integrative hepatic transcriptome analysis identifies biomarkers of non-alcoholic steatohepatitis activity and fibrosis progression 87
Increased Pre-Hepatic Insulin Levels Are Directly Related to Nash, Fibrogenesis and Fibrosis in Non Diabetic NAFLD Patients but Not in Type 2 Diabetes 86
Predisposition to diabetes is related to insulin resistance in NAFLD patients and to decreased insulin secretion in HCV patients 81
Longitudinal prognostic value of the most common algorithms for fibrosis in non-alcoholic fatty liver disease: An international study in non-cirrhotic, biopsy-proven patients 81
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver disease 81
Importance of HLA-B in the sustained virological response in patients with chronic hepatitis C treated with peg-IFN and ribavirin 80
Clinical Characteristics and Long-Term Outcomes of Lean Caucasian Patients with Non- Alcoholic Fatty Liver Disease. a Longitudinal International Study. 77
NASH-related liver carcinogenesis is critically affected by hypoxia-inducible factor 2 alpha 77
Selenoprotein P levels discriminate the degree of hepatic steatosis and are related to the NAS score in patients with non-alcoholic fatty liver disease 76
Metabolic Syndrome after liver transplantation: have risk factors changed over time? 75
Diagnostic accuracy of soluble sCD163 for the detection of severe fibrosis in patients with Non-Alcoholic Fatty Liver Disease 74
Epidemiology and Natural History of Patients with NAFLD 70
Performance of the PRO-C3 collagen neo-epitope biomarker in non-alcoholic fatty liver disease 70
Application of serum cytokeratin-19 fragments (CYFRA 21-1) in predicting the prognosis of patients with hepatocellular carcinoma 69
Risk of developing hepatocellular carcinoma in patients with cirrhosis of viral etiology evaluated by the combination of alphafetoprotein, protein induced by vitamin K absence or antagonist-II and glypican-3 68
Is vitamin B12 serum level involved in the spread of Helicobacter pylori? 52
Ductular reaction predicts the progression of non-alcoholic fatty liver disease 48
Risk of developing hepatocellular carcinoma (HCC) in patients with cirrhosis of viral etiology evaluated by the association of alpha-fetoprotein (AFP), protein induced by vitamin K absence or antagonist-II (PIVKA-II) and glypican-3 (GPC-3) 47
Interplay between metabolic derangement, hepatic fibrogenesis and macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease 40
Molecular mechanisms of hepatic fibrosis in chronic liver diseases 40
The long-term impact of baseline PNPLA3 genotyping in patients with NAFLD. A longitudinal multicentre study 36
Liver stiffness measurement by fibroscan predicts the occurrence of liver-related events and death in patients with NAFLD-related compensated advanced chronic liver disease 35
Cross-Sectional and Longitudinal Performance of Non-Invasive Tests of Liver Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease 18
Totale 9.561
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.681
article - articoli 0
book - libri 0
conference - conferenze 5.356
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.037
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019133 0 0 0 0 0 0 0 0 0 0 87 46
2019/20201.180 38 30 29 84 100 137 112 116 155 173 119 87
2020/20211.976 101 131 113 135 166 159 187 177 211 258 144 194
2021/20222.114 141 188 156 189 194 119 178 158 187 193 248 163
2022/20231.653 148 144 60 123 143 272 130 152 182 88 93 118
2023/20241.391 135 146 155 160 189 153 125 159 57 97 15 0
Totale 9.561